Cardiovascular diseases
July 23, 2017

The biomarker and causal roles of homoarginine in the development of cardiometabolic diseases: an observational and Mendelian randomization analysis

Seppälä et al. Scientific Reports 2017:7(1130)

In this paper, researchers used Mendelian randomization to investigate High L-homoarginine (hArg) levels.

The results found that lifetime exposure to higher levels of circulating hArg does not seem to alter cardiometabolic disease risk.